Dr. Anne Metje Van Genderen

Biography

Anne Metje van Genderen earned a Bachelor degree in Pharmaceutical Sciences and a Master degree in Drug Innovation from Utrecht University. In 2023, she obtained her PhD from Utrecht University with a thesis entitled “Engineering (vascularized) proximal tubule, guide functionality.” During her PhD, she received the Materials Driven Regeneration Young Talent Incentive grant, allowing her to conduct five months of research at Harvard Medical School under the supervision of Dr. Yu Shrike Zhang. Following her doctoral work, Anne Metje was involved in a postdoc project titled Virtual Human Platform Safety Assessment (VHP4Safety) consortium, focusing on studying drug-induced nephrotoxicity using induced pluripotent stem cell derived kidney organoids. As of March 2024, Anne Metje holds the position of Assistant Professor in the Division of Pharmacology at the Utrecht Institute of Pharmaceutical Sciences, Utrecht University. Her research primarily focuses on mimicking kidney functions in vitro to study diseases and work toward innovative therapies, specifically exploring (bio)materials that can guide kidney maturation in efforts to build tissue that can partially replace kidney functions.

Research Interests

Experience